Literature DB >> 11173909

Role of granuloma in the immunopathogenesis of Crohn's disease.

T Matsumoto1, S Nakamura, Y Jin-No, Y Sawa, J Hara, N Oshitani, T Arakawa, H Otani, H Nagura.   

Abstract

Inflammatory bowel diseases (ulcerative colitis and Crohn's disease) are chronic long-lasting inflammatory diseases with yet unknown etiology. Recent advancement revealed that both diseases are associated with genetic predisposition and environmental factors such as luminal microorganisms and antigens. Crohn's disease is associated with histopathologic features such as granuloma formation and longitudinal ulceration. In this article we describe the role of granuloma in the immunopathogenesis of Crohn's disease. Granuloma of Crohn's disease may play crucial roles as antigen-presenting cites to memory type T cells, which leads to activation and proliferation of T cells. Antigens presented at granuloma may be closely related to the disease. Copyright 2001 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11173909     DOI: 10.1159/000051910

Source DB:  PubMed          Journal:  Digestion        ISSN: 0012-2823            Impact factor:   3.216


  9 in total

1.  Platelets in inflammatory bowel disease.

Authors:  Takayuki Matsumoto
Journal:  J Gastroenterol       Date:  2006-01       Impact factor: 7.527

2.  Induction and rescue of Nod2-dependent Th1-driven granulomatous inflammation of the ileum.

Authors:  Amlan Biswas; Yuen-Joyce Liu; Liming Hao; Atsushi Mizoguchi; Nita H Salzman; Charles L Bevins; Koichi S Kobayashi
Journal:  Proc Natl Acad Sci U S A       Date:  2010-08-02       Impact factor: 11.205

3.  Impaired neutrophil chemotaxis in Crohn's disease relates to reduced production of chemokines and can be augmented by granulocyte-colony stimulating factor.

Authors:  M W N Harbord; D J B Marks; A Forbes; S L Bloom; R M Day; A W Segal
Journal:  Aliment Pharmacol Ther       Date:  2006-08-15       Impact factor: 8.171

Review 4.  Frequency of epithelioid granulomas in colonoscopic biopsy specimens from paediatric and adult patients with Crohn's colitis.

Authors:  C A Rubio; A Orrego; G Nesi; Y Finkel
Journal:  J Clin Pathol       Date:  2007-02-09       Impact factor: 3.411

Review 5.  From inflammatory bowel disease to colorectal cancer: what's the role of miRNAs?

Authors:  Mostafa Vaghari-Tabari; Niloufar Targhazeh; Soheila Moein; Durdi Qujeq; Forough Alemi; Maryam Majidina; Simin Younesi; Zatollah Asemi; Bahman Yousefi
Journal:  Cancer Cell Int       Date:  2022-04-11       Impact factor: 5.722

6.  Serum Cytokine Profiles in Children with Crohn's Disease.

Authors:  Ekaterina Vasilyeva; Sayar Abdulkhakov; Georgi Cherepnev; Ekaterina Martynova; Irina Mayanskaya; Alina Valeeva; Rustam Abdulkhakov; Dilyara Safina; Svetlana Khaiboullina; Albert Rizvanov
Journal:  Mediators Inflamm       Date:  2016-12-13       Impact factor: 4.711

7.  The BTNL2 G16071A gene polymorphism increases granulomatous disease susceptibility: A meta-analysis including FPRP test of 8710 participants.

Authors:  Xiang Tong; Yao Ma; Xundong Niu; Zhipeng Yan; Sitong Liu; Bo Peng; Shifeng Peng; Hong Fan
Journal:  Medicine (Baltimore)       Date:  2016-07       Impact factor: 1.889

8.  Gastrocnemius Myalgia as a Rare Initial Manifestation of Crohn's Disease.

Authors:  Atsumu Osada; Hiroaki Yamada; Sayuri Takehara; Yuuichiro Tozuka; Taito Fukushima; Hiroyuki Oka; Hiroshi Okazaki; Shohei Nagaoka
Journal:  Intern Med       Date:  2018-02-28       Impact factor: 1.271

9.  Significance of granulomas in the outcomes of Crohn's disease patients.

Authors:  Marie Christelle Saade; Hisham Wehbe; Fadi H Mourad; Mohammad Hosni; Fadi F Francis; Maha Makki; David G Binion; Hani Tamim; Francis A Farraye; Talha Malik; Jana G Hashash
Journal:  Ann Gastroenterol       Date:  2022-07-11
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.